GSEA enrichment analysis results for high and low expression of PPARα and NR1H4 in BA patients, and GSEA results excluding patients with hepatitis B, normal liver, liver cancer, and non-BA cholestasis. This evidence concerns the gene NR1H4 and breast angiosarcoma.